ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

INBX Inhibrx Inc

34.15
0.14 (0.41%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Inhibrx Inc INBX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.14 0.41% 34.15 16:22:21
Open Price Low Price High Price Close Price Previous Close
34.35 33.87 34.45 34.15 34.01
more quote information »

Recent News

Date Time Source Heading
3/11/202415:26EDGAR2Form 144 - Report of proposed sale of securities
3/08/202415:08EDGAR2Form 144 - Report of proposed sale of securities
3/08/202414:28EDGAR2Form 144 - Report of proposed sale of securities
3/06/202415:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202413:58EDGAR2Form 144 - Report of proposed sale of securities
3/04/202417:26EDGAR2Form 144 - Report of proposed sale of securities
2/29/202416:26EDGAR2Form PREM14A - Preliminary proxy statements relating to..
2/28/202408:15PRNUSInhibrx Reports Fourth Quarter and Fiscal Year 2023..
2/28/202408:12EDGAR2Form 8-K - Current report
2/28/202408:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/14/202415:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/06/202415:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
1/26/202411:12PRNUSKuehn Law Encourages DOC, BATL, KAMN, and INBX Investors to..
1/23/202416:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
1/23/202405:38EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
1/23/202405:35EDGAR2Form 8-K - Current report
1/23/202405:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
1/23/202404:40IHMARKETNEWSWall Street Highlights: Vroom Shuts Down Online Car Sales,..
1/23/202400:00PRNUSInhibrx Announces Sale of INBRX-101 to Sanofi for an..
11/09/202315:03EDGAR2Form 8-K - Current report
11/09/202315:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202315:00PRNUSInhibrx Reports Third Quarter 2023 Financial Results and..
11/02/202308:16EDGAR2Form 8-K - Current report
11/02/202308:15PRNUSInhibrx Announces Preliminary Data from the Phase 1 Trial of..
10/18/202315:00PRNUSInhibrx Announces Participation in Upcoming Scientific..
9/19/202315:03EDGAR2Form 8-K - Current report
9/19/202315:00PRNUSInhibrx Retains Rights to INBRX-101 for the Treatment of..
8/31/202315:06EDGAR2Form D - Notice of Exempt Offering of Securities
8/29/202308:03EDGAR2Form 8-K - Current report
8/29/202308:00PRNUSInhibrx Announces $200 Million Private Placement Financing
8/07/202315:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202315:00PRNUSInhibrx Reports Second Quarter 2023 Financial Results and..
5/30/202308:46DJNInhibrx Granted FDA Fast Track Designation for INBRX-101
5/30/202308:00PRNUSInhibrx Granted Fast Track Designation for INBRX-101 for the..
5/08/202315:05PRNUSInhibrx Reports First Quarter 2023 Financial Results and..

Your Recent History

Delayed Upgrade Clock